Table 1. Correlation between the factors and clinicopathologic characteristics in HCC (n=323).
Clinicopathological indexes | PDEF Low | PDEF High | P | |
---|---|---|---|---|
Age, years | ≤50 | 81 | 85 | 0.698 |
>50 | 80 | 77 | ||
Sex | Female | 21 | 25 | 0.539 |
Male | 140 | 137 | ||
HBsAg | Negative | 22 | 23 | 0.890 |
Positive | 139 | 139 | ||
AFP, ng/mL | ≤20 | 38 | 58 | 0.016 |
>20 | 123 | 104 | ||
γ-GT, U/L | ≤54 | 61 | 70 | 0.330 |
>54 | 100 | 92 | ||
Liver cirrhosis | No | 15 | 21 | 0.298 |
Yes | 146 | 141 | ||
Tumor size, cm | ≤5 | 72 | 92 | 0.030 |
>5 | 89 | 70 | ||
Tumor number | Single | 141 | 135 | 0.279 |
Multiple | 20 | 27 | ||
Microvascular invasion | Absence | 76 | 99 | 0.012 |
Present | 85 | 63 | ||
Tumor encapsulation | Complete | 81 | 83 | 0.868 |
None | 80 | 79 | ||
Tumor differentiation | I+II | 120 | 135 | 0.052 |
II+IV | 41 | 27 | ||
TNM stage | I | 69 | 85 | 0.084 |
II III | 92 | 77 |
HBsAg: hepatitis B surface antigen; AFP: a-fetoprotein; γ-GT: γ-glutamyl transferase; TNM: tumor-nodes metastasis.